FOLH1 and neoplasm: Additionally, biomarkers such as KPROD, Androgen Receptor Splice Variant 7, circulating tumor DNA, or Prostate-Specific Membrane Antigen Positron Emission Tomography imaging, which could enhance predictive accuracy, were not used in the current study [21].